Furthermore, in glioma, again the CD45 expression level provided the basis for microglia and macrophage distinction revealing CD45low cells expressing negligible or no CD49D, whereas CD45high cells showed high CD49D expression [59]. The gene discussed is PTPRC; the disease is central nervous system cancer.